Related content

Efficacy prediction of cevimeline in patients with Sjögren’s syndrome

By Yamada Hiroyuki   Nakagawa Yoichi   Wakamatsu Ei   Sumida Takayuki   Yamachika Shigeo   Nomura Yoshiaki   Mishima Kenji   Saito Ichiro  

Clinical Rheumatology, Vol. 26, Iss. 8, 2007-08 ,pp. : 1320-1327

Springer Publishing Company

Access to resources Recommend Favorite

Characterization of cognitive dysfunction in Sjögren’s syndrome patients

By Epstein Lynn   Masse Gina   Harmatz Jerold   Scott Tammy   Papas Athena   Greenblatt David  

Clinical Rheumatology, Vol. 33, Iss. 4, 2014-04 ,pp. : 511-521

Springer Publishing Company

Access to resources Recommend Favorite

Sjögren’s syndrome

By Moutsopoulos Haralampos M   Tzioufas Athanasios G  

International Journal of Clinical Rheumatology, Vol. 8, Iss. 5, 2013-10 ,pp. : 517-520

Future Medicine

Access to resources Recommend Favorite

Validation of different sets of criteria for the diagnosis of Sjögren's syndrome in Japanese patients

By Tsuboi Hiroto  

Modern Rheumatology, Vol. 23, Iss. 2, 2013-03 ,pp. : 219-225

Springer Publishing Company

Access to resources Recommend Favorite

Thyroid disease in Sjögren’s syndrome

By Jara Luis   Navarro Carmen   Brito-Zerón María del   García-Carrasco Mario   Escárcega Ricardo   Ramos-Casals Manuel  

Clinical Rheumatology, Vol. 26, Iss. 10, 2007-10 ,pp. : 1601-1606

Springer Publishing Company

Access to resources Recommend Favorite